Publications by authors named "R Vilain"

Claim this Profile
P
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
Ryan J Duchatel, Evangeline R Jackson, Sarah G Parackal, Dylan Kiltschewskij, Izac J Findlay, Ricardo E Vilain

J Clin Invest· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory pseudotumour arising secondary to VEXAS syndrome.
Alex Holmes, Aung Thant, Rachael Correy, Ricardo Vilain

Pathology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge.
Andre van der Westhuizen, Megan Lyle, Moira C Graves, Xiaoqiang Zhu, Jason W H Wong, Ricardo E Vilain

Cancer Res Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.
Richard A Scolyer, Victoria Atkinson, David E Gyorki, Duncan Lambie, Sandra O'Toole, Ricardo E Vilain

Pathology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma Multiforme.
Cassandra Griffin, Ricardo Vilain, Simon King, Sandy Nixon, Alisha Gooley

Biomark Insights· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis